Seres Therapeutics
About:
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Website: http://www.serestherapeutics.com
Twitter/X: SeresTX
Top Investors: RA Capital Management, Sofinnova Investments, Mayo Clinic, Oaktree Capital Management, CARB-X
Description:
Seres Therapeutics is a clinical-stage biotherapeutic company that develops ecobiotic therapeutic products. They engaged in developing biological drugs which are referred to as ecobiotic microbiome therapeutics. The company is a group of experts in microbiome research and drug development. Its executive team, board of directors, and scientific advisory board have a wealth of experience in the development, regulatory approval, and profitable commercialization of a wide range of therapeutic products.
$538M
$100M to $500M
Cambridge, Massachusetts, United States
2010-01-01
info(AT)serestherapeutics.com
David Berry, Geoffrey von Maltzahn, Noubar Afeyan
101-250
2023-04-27
Public
© 2025 bioDAO.ai